Likewise, Ma and colleagues [33] studied the predictive usefulness of CA125 (MUC16) and other biomarkers in 164 individuals with stage I NSCLC who had surgery (101 men, 63 women). Here, MUC16 is linked to non-small cell lung carcinoma.